Preview

Злокачественные опухоли

Расширенный поиск

ЦИТОРЕДУКЦИЯ С ИНТРАОПЕРАЦИОННОЙ ГИПЕРТЕРМИЧЕСКОЙ ХИМИОПЕРФУЗИЕЙ КАК ПРИЗНАННЫЙ МЕТОД ЭФФЕКТИВНОГО ЛЕЧЕНИЯ БОЛЬНЫХ С ПЕРИТОНЕАЛЬНЫМ КАРЦИНОМАТОЗОМ ПРИ РАКЕ ТОЛСТОЙ КИШКИ

https://doi.org/10.18027/2224-5057-2012-2-116-120

Полный текст:

Аннотация

.

Об авторах

В. Гущин
Institute for Cancer Care at Mercy, Балтимор
Соединённые Штаты Америки


М. Д. Тер-Ованесов
РНИМУ им. Н.И.Пирогова, КБ УДП РФ, Москва
Россия


Список литературы

1. Sadeghi B, Arvieux C, Glehen O et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88:358-363.

2. Jayne DG, Fook S, Loi C et al. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002;89:1545-1550.

3. Franko J, Shi Q, Goldman CD et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012;30:263-267.

4. Sugarbaker PH. A perspective on clinical research strategies in carcinoma of the large bowel. World J Surg. 1991;15:609-616.

5. Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon. Ann Surg. 1994;219:109-111.

6. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg. 1995;221:124-132.

7. Sugarbaker PH. Peritonectomy procedures. Cancer Treat Res. 2007;134:247-264.

8. Portilla AG, Shigeki K, Dario B et al. The intraoperative staging systems in the management of peritoneal surface malignancy. J Surg Oncol. 2008;98:228-231.

9. Verwaal VJ, van RS, de BE et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737-3743.

10. Verwaal VJ, Bruin S, Boot H et al. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008;15:2426-2432.

11. Cao C, Yan TD, Black D et al. A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2009;16:2152-2165.

12. Elias D, Delperro JR, Sideris L et al. Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials. Ann Surg Oncol. 2004;11:518-521.

13. Elias D, Lefevre JH, Chevalier J et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27:681-685.

14. Mahteme H, Hansson J, Berglund A et al. Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study. Br J Cancer. 2004;90:403-407.

15. Franko J, Ibrahim Z, Gusani NJ et al. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion versus systemic chemotherapy alone for colorectal peritoneal carcinomatosis. Cancer. 2010;116:3756-3762.

16. Chua TC, Morris DL, Saxena A et al. Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: a multicenter study. Ann Surg Oncol. 2011;18:1560-1567.

17. Elias D, Gilly F, Boutitie F et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol. 2010;28:63-68.

18. Kianmanesh R, Scaringi S, Sabate JM et al. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg. 2007;245:597-603.

19. Kecmanovic DM, Pavlov MJ, Ceranic MS et al. Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy. Eur J Surg Oncol. 2005;31:147-152.

20. Glehen O, Kwiatkowski F, Sugarbaker PH et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22:3284-3292.

21. Glehen O, Cotte E, Schreiber V et al. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg. 2004;91:747-754.

22. Pestieau SR, Sugarbaker PH. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management. Dis Colon Rectum. 2000;43:1341-1346.

23. Verwaal VJ, van RS, Witkamp A et al. Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2005;12:65-71.

24. Yan TD, Morris DL. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care? Ann Surg. 2008;248:829-835.

25. Vaira M, Cioppa T, D’Amico S et al. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years. In Vivo. 2010;24:79-84.

26. Cavaliere F, De SM, Virzi S et al. Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O. Eur J Surg Oncol. 2011;37:148-154.

27. Levine EA, Blazer DG, III, Kim MK et al. Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes. J Am Coll Surg. 2012;214:599-606.

28. Noura S, Ohue M, Shingai T et al. Effects of intraperitoneal chemotherapy with mitomycin C on the prevention of peritoneal recurrence in colorectal cancer patients with positive peritoneal lavage cytology findings. Ann Surg Oncol. 2011;18:396-404.

29. Esquivel J, Chua TC, Stojadinovic A et al. Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol. 2010;102:565-570.


Для цитирования:


Гущин В., Тер-Ованесов М.Д. ЦИТОРЕДУКЦИЯ С ИНТРАОПЕРАЦИОННОЙ ГИПЕРТЕРМИЧЕСКОЙ ХИМИОПЕРФУЗИЕЙ КАК ПРИЗНАННЫЙ МЕТОД ЭФФЕКТИВНОГО ЛЕЧЕНИЯ БОЛЬНЫХ С ПЕРИТОНЕАЛЬНЫМ КАРЦИНОМАТОЗОМ ПРИ РАКЕ ТОЛСТОЙ КИШКИ. Злокачественные опухоли. 2012;2(2):116-120. https://doi.org/10.18027/2224-5057-2012-2-116-120

For citation:


., . . Malignant tumours. 2012;2(2):116-120. (In Russ.) https://doi.org/10.18027/2224-5057-2012-2-116-120

Просмотров: 255


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2224-5057 (Print)
ISSN 2587-6813 (Online)